Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02522 (Long intergenic non-protein coding RNA 2522) is a human gene that encodes a long non-coding RNA transcript longer than 200 nucleotides[1][3]. It is located in intergenic regions of the genome and does not appear to give rise to any protein product. LINC02522 is part of a large family of lincRNAs, which typically modulate gene expression via chromatin remodeling, transcriptional regulation, or RNA-mediated signaling, though no specific function or disease connection has been assigned to this transcript[3]. Current knowledge is limited to genomic annotation, and LINC02522 is not presently recognized as a therapeutic target, disease gene, or clinically actionable biomarker[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2522 (LINC02522).